Fundamental Analysis
89 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +65.9% | +46.2% | 3 / 3 | -36.2% | +7.04 pp | +7.33 pp | +21.4% | 0.31 | 5.15 | 101 | −36,2% | 12,0 | +67,3% | 5.15 | 8.65 | −40,4% |
| Pts | 12 | 12 | 12 | 0 | 12 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 17.400 (close price on 2026-10-19)EPS (TTM): 3.376
Financial charts
1.Revenue & growth
VND bn101Q2/26
1.Revenue & growth
VND bn101Q2/26
2.Profit & growth
VND bn11,8Q2/26
3.Profit mix (Penman)
VND bn54,7Q2/26
4.Margins & cost structure
%16.1%Q2/26
5.Returns & cash cycle
% · days25.9%Q2/26
6.Earnings quality & cash
VND bn81,9Q2/26
7.Asset structure
VND bn495Q2/26
8.Funding & debt health
VND bn · times495Q2/26
9.Revenue backlog
VND bn45,6Q2/26
10.Valuation
times · %5,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %893Q2/26
Adjusted EPS growth, latest quarter
65.9%
Average adjusted EPS growth, 3 quarters
46.2%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26